Establishing secure connection…Loading editor…Preparing document…

Securities Purchase Agreement

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (this "Agreement") is dated as of January 11, 2000 among IGEN International, Inc., a Delaware corporation (the "Company"), and the various purchasers identified and listed on Schedule I hereto (each referred to herein as a "Purchaser" and, collectively, the "Purchasers").

WHEREAS, the Company and the Purchasers are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Rule 506 under Regulation D as promulgated by the United States Securities and Exchange Commission (the "Commission") under Section 4(2) of the Securities Act of 1933, as amended (the "Securities Act");

WHEREAS, subject to the terms and conditions set forth in this Agreement, the Company desires to issue and sell to the Purchasers, and the Purchasers desire to acquire from the Company, an aggregate principal amount of $35,000,000 of 5% Subordinated Convertible Debentures due January 11, 2005 (the "Debentures"), in the form of Exhibit A annexed hereto and warrants (the "Warrants") to purchase 282,258 shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), in the form of Exhibit B annexed hereto; and

WHEREAS, contemporaneously with the execution and delivery of this Agreement, the parties hereto are executing and delivering a Registration Rights Agreement in the form of Exhibit C annexed hereto (the "Registration Rights Agreement") pursuant to which the Company has agreed to provide certain registration rights under the Securities Act and the rules and regulations promulgated thereunder, and applicable state securities laws.

NOW THEREFORE, in consideration of the promises and mutual covenants and agreements hereinafter, the Company and the Purchasers hereby agree as follows:

ARTICLE I. PURCHASE AND SALE OF THE DEBENTURES AND WARRANTS

1.1 PURCHASE AND SALE.

Subject to the terms and conditions set forth herein, the Company shall issue and sell to each Purchaser, and each Purchaser, severally and not jointly, shall purchase from the Company on the Closing Date (as defined below), the principal amount of Debentures as set forth for such Purchaser on Schedule I.

1.2 CLOSING.

a. The Closing. The closing of the purchase and sale of the Debentures and the issuance of the Warrants (the "Closing") shall take place at the offices of Akin, Gump, Strauss, Hauer & Feld, L.L.P., 590 Madison Avenue, New York, New York 10022, or by transmission by facsimile and overnight courier, immediately following the execution hereof, or such later date or different location as the parties shall agree, but not prior to the date that the conditions set forth in Section 4.1 have been satisfied or waived by the appropriate party (the "Closing Date").

At the Closing:

• Each Purchaser shall deliver, as directed by the Company, its portion of the purchase price as set forth next to its name on Schedule I in United States dollars in immediately available funds to an account or accounts designated in writing by the Company;

• The Company shall deliver to each Purchaser a Debenture(s) in the form of Exhibit A hereto representing the principal amount of Debentures purchased by such Purchaser as set forth on Schedule I hereto;

• The Company shall deliver to each Purchaser a Warrant, in the form of Exhibit B hereto, representing the right to acquire the number of shares of Common Stock as set forth on Schedule I hereto; and

• The parties shall execute and deliver each of the documents referred to in Section 4.1 hereof.

ARTICLE II. REPRESENTATIONS AND WARRANTIES

2.1 REPRESENTATIONS, WARRANTIES AND AGREEMENTS OF THE COMPANY.

The Company hereby makes the following representations and warranties to each of the Purchasers. Any information disclosed in any Schedule hereto shall be deemed to have been disclosed in all Schedules hereto.

2.2 REPRESENTATIONS AND WARRANTIES OF THE PURCHASERS.

Each of the Purchasers, severally and not jointly, hereby represents and warrants to the Company as follows:

ARTICLE III. OTHER AGREEMENTS

3.1 TRANSFER RESTRICTIONS.

Any transfer of the Debentures, the Warrants, the Debenture Shares or the Warrant Shares is subject to the restrictions set forth herein and applicable securities laws.

3.2 STOP TRANSFER INSTRUCTION.

The Company may not make any notation on its records or give instructions to any transfer agent of the Company which enlarge the restrictions on transfer set forth in Section 3.1.

3.3 FURNISHING OF INFORMATION.

As long as any Purchaser owns the Debentures, the Warrants, the Debenture Shares or the Warrant Shares, the Company will continue to furnish required reports and information.

3.4 BLUE SKY LAWS.

The Company shall qualify the Debenture Shares and the Warrant Shares under applicable state securities laws as requested by the Purchasers.

3.5 INTEGRATION.

The Company shall not sell, offer for sale or solicit offers to buy any security that would be integrated with the offer or sale of the Debentures or Warrants in a manner requiring registration under the Securities Act.

3.6 LISTING, REGISTRATION AND RESERVATION OF DEBENTURE SHARES AND WARRANT SHARES.

The Company shall take all steps necessary to list and reserve the Required Minimum Shares and maintain such listing.

3.7 NOTICE OF BREACHES.

The Company and each Purchaser shall give prompt written notice of any breach or event likely to cause a breach of any representation, warranty or covenant.

3.8 FORM D.

The Company agrees to file a Form D with respect to the Debentures and Warrants as required by Rule 506 under Regulation D.

3.9 FUTURE FINANCINGS.

If the Company offers New Securities while any Debentures are outstanding, the Purchasers shall have a pro rata right to purchase such securities on the terms described herein.

3.10 USE OF PROCEEDS.

The Company shall use the proceeds from the sale of the Debentures and the exercise of the Warrants for capital expenditures, research and development, expansion of sales, customer support and marketing functions, working capital and possible strategic acquisitions.

3.11 TRANSACTIONS WITH AFFILIATES.

So long as any Debentures or Warrants are outstanding, the Company shall not enter into certain related party transactions except as permitted herein.

3.12 TRANSFER AGENT INSTRUCTIONS.

At the Closing the Company shall issue irrevocable instructions to its transfer agent to issue certificates for the Debenture Shares and/or the Warrant Shares as specified by each Purchaser.

3.13 ORDINARY COURSE BROKERAGE AND TRADING.

Subject to compliance with applicable securities laws and Nasdaq regulations, the Purchasers may engage in ordinary course brokerage and trading activities in respect of the Company's Common Stock.

3.14 COMMERCIALLY REASONABLE EFFORTS.

Each of the parties hereto shall use all commercially reasonable efforts to satisfy each of the conditions to be satisfied by it.

3.15 NO VIOLATION OF APPLICABLE LAW.

If any redemption required under this Agreement is prohibited by Delaware law, it shall be effected as soon as permitted under such law.

3.16 MATERIAL INFORMATION.

Any material non-public information provided by the Company to the Purchasers shall cease to be material non-public information by the date the Initial Registration Statement is declared effective.

ARTICLE IV. CONDITIONS

4.1 CLOSING CONDITIONS.

The Closing is subject to the satisfaction or waiver of the conditions set forth herein.

ARTICLE V. INDEMNIFICATION

5.1 INDEMNIFICATION.

The Company shall defend, protect, indemnify and hold harmless each Purchaser and the Indemnitees as described herein.

ARTICLE VI. MISCELLANEOUS

This Agreement contains the entire understanding of the parties with respect to the subject matter hereof and supersedes all prior agreements and understandings.

Execution Details

Private offering acknowledgement

Investment risk acknowledgement

Transfer restrictions acknowledgement

Indemnification acknowledgement

Company Signature

Authorized Signatory

Purchaser Signature

Authorized Signatory

Enter text✕

What a Securities Purchase Agreement Is and when it applies

A Securities Purchase Agreement (SPA) is a legally binding contract that documents the sale and purchase of equity or debt securities between an issuer and investors. It identifies the securities being issued, the purchase price, closing mechanics, representations and warranties, conditions to closing, covenants, and indemnities. An SPA is used to record terms agreed in term sheets or investment negotiations and allocates risks between parties. Private offerings commonly use SPAs to support blue sky filings, tax reporting, and corporate minute book updates.

Why a clear, complete SPA matters for investors and issuers

A well-drafted SPA reduces ambiguity about price, ownership, and post-closing obligations, helps satisfy closing conditions, and provides documentary evidence for tax and securities compliance. Electronic execution of SPAs is generally enforceable under the ESIGN Act (15 U.S.C. ch. 96) and UETA where adopted, subject to statutory exceptions.

Why a clear, complete SPA matters for investors and issuers

Who typically prepares and signs a Securities Purchase Agreement

Multiple parties touch an SPA: corporate counsel and executives from the issuer, lead investors and their counsel, placement agents, and transfer agents or corporate secretaries who update records after closing.

  • Lead investors and investment groups often negotiate price, protective provisions, and closing deliverables on behalf of subscribing parties.
  • Issuing company officers and in-house or external counsel prepare disclosure schedules, board approvals, and post-closing corporate actions.
  • Service providers such as escrow agents, transfer agents, and accountants manage funds flow, share issuance, and tax reporting.

Accurate parties, signature authority, and attachments reduce post-closing disputes and speed recordkeeping and compliance tasks.

Roles and typical signatories

Lead Investor

Lead investors execute the SPA, negotiate economic and protective terms, perform diligence, and coordinate funds transfer and blue sky filings on behalf of subscribing investors.

Company Representative

Authorized officers or corporate officers sign for the issuer, represent corporate authority and compliance, and are responsible for delivering related corporate approvals and closing certificates.

Essential fields to include in the SPA

Buyer Name: Full legal entity name
Seller/Issuer: Registered corporate name
Securities Type: Common or preferred
Purchase Price: Price per share
Closing Date: MM/DD/YYYY format
Signatures: Printed name and date

Primary sections you will see in a professional SPA

A complete SPA organizes the transaction into distinct legal and operational sections so that responsibilities, timelines, and obligations are unambiguous and enforceable.

Purchase Terms

Defines the securities issued, number of shares or principal amount, consideration, and any adjustments to price or closing payments, plus mechanics for wire instructions and escrow.

Representations

Mutual and party-specific representations about authority, capitalization, accuracy of disclosures, financial statements, and outstanding liabilities that underpin reliance at closing.

Conditions to Closing

Conditions precedent that must be satisfied or waived before funds and shares exchange hands, such as board approvals, regulatory consents, and third-party waivers.

Covenants

Pre- and post-closing promises, including restrictive covenants, use of proceeds, ongoing reporting obligations, and further assurances required to effect the transaction.

Indemnification

Allocation of risk for breaches of reps, tax liabilities, or other losses and procedures for notice, defense, and settlement of claims after closing.

Miscellaneous Provisions

Governing law, dispute resolution, amendment process, assignment restrictions, survival of certain clauses, and notices address legal administration and remedies.

Step-by-step: completing a Securities Purchase Agreement

Follow these sequential steps to prepare, review, and execute an SPA with minimal delays and clear compliance with contract and securities requirements.

  • 01
    Assemble deal terms: Confirm price, securities type, and closing mechanics.
  • 02
    Prepare draft SPA: Populate core sections and attach schedules.
  • 03
    Legal and tax review: Have counsel review blue sky and tax implications.
  • 04
    Execute and record: Obtain signatures and update corporate records.

How to configure an online signing workflow for an SPA

Configure your digital workflow to match the transaction order, authentication needs, and required attachments before sending the SPA for signatures.

Field Configuration
Signing Order Sequential order: lead investor, issuer, escrow agent
Authentication Email plus SMS code or ID verification as needed
Expiration Set link expiry to limit exposure
Reminders Automated reminders for pending signers

Technical considerations for secure e-signature and distribution

Ensure your chosen platform supports required authentication, audit trails, integrations, and file formats prior to execution.

  • Integrations: Salesforce, NetSuite, and Google Workspace integrations available
  • File formats: PDF and DOCX supported for upload and signed output
  • Authentication: Supports email, SMS, and advanced verification

Verify audit trail detail, encryption standards, and retention exports to satisfy legal, tax, and recordkeeping obligations.

Typical routing and delivery steps for an executed SPA

After signing, route the final SPA and related exhibits to the right recipients and repositories to complete the transaction and enable downstream filings.

  • Issuer Corporate Records: Company secretary receives signed SPA for minute book updates.
  • Lead Investor Counsel: Lead counsel retains copy and circulates to subscribing investors.
  • Escrow / Closing Agent: Escrow receives executed SPA to release funds or shares.
  • Accounting and Tax: Accounting receives documents for tax reporting and cost basis.

Key dates and reporting deadlines tied to the SPA

Track and calendar closing, delivery, and post-closing filing deadlines so parties meet transfer, tax, and regulatory obligations.

Closing Date:

The agreed date when funds and securities exchange hands.

Funding Deadline:

Date by which wired funds must be received at escrow.

Share Issuance:

Date issuer issues or allocates shares in cap table.

Tax Reporting:

Issuer prepares required tax statements for applicable year.

Post-Closing Deliverables:

Dates for delivering opinions, officer certificates, or investor confirmations.

Milestone timeline from term sheet to closing

A concise milestone sequence helps coordinate diligence, approvals, and the mechanics of funding and transfer.

01

Term Sheet Signed

Agreed commercial terms and price are documented.

02

Definitive SPA Drafted

Prepare and circulate the full SPA with exhibits.

03

Conditions Satisfied

Board approvals, consents, and regulatory conditions cleared.

04

Closing Completed

Funds wired, shares issued, and final copies distributed.

Common mistakes that delay or invalidate a closing

  • Using informal or incorrect legal entity names that prevent accurate record transfers and tax reporting.
  • Failing to attach or populate disclosure schedules, creating gaps in representations or post-closing disputes.
  • Skipping investor accreditation checks or blue sky analysis, which can trigger regulatory violations and rescission risk.
  • Relying on unsigned side letters or verbal agreements that contradict the SPA's written terms and cause enforceability issues.

Penalties and legal risks if the SPA is incorrect

Tax Reporting: Potential penalties for incorrect information
Securities Violations: State blue sky noncompliance risk
Contract Breach: Damages or rescission exposure
Withholding Liability: Backup withholding consequences
Transfer Defect: Shares not properly recorded
Invalid Signatures: Enforceability disputes

Real-world examples of SPA usage and outcomes

These customer stories illustrate practical uses of electronic workflows and SPA document management in live transactions.

Optica Ventures (COO)

Optica used a digital signing workflow to execute investor documents quickly

  • The team avoided in-person signatures by routing exhibits electronically
  • The result was faster closings and consistent recordkeeping across investor groups, as reported by Brian Fitzgibbons, COO.

Martin Properties (Founder)

Martin Properties processed multiple investor SPAs online during a property fund raise

  • The company used remote signing and secure storage
  • Tim Martin noted that the approach maintained compliance and allowed investors to sign from mobile devices without office visits.

Comparing eSignature providers for signing a Securities Purchase Agreement

Basic vendor comparisons show pricing, trial availability, bulk-send capability, audit trail presence, and envelope limits; signNow is listed first per vendor comparison convention.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies by plan Varies by plan Varies by plan Varies by plan
Bulk Send Yes Yes Yes Yes Varies
Audit Trail Yes Yes Yes Yes Yes
Envelope Cap No cap 100 envelopes/user/year Varies Varies Varies

Frequently asked questions about SPAs and electronic execution

Answers to common legal, procedural, and technical questions about preparing, signing, and storing a Securities Purchase Agreement.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users